Search

Your search keyword '"tumor-cells"' showing total 270 results

Search Constraints

Start Over You searched for: Descriptor "tumor-cells" Remove constraint Descriptor: "tumor-cells"
270 results on '"tumor-cells"'

Search Results

1. A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia

2. Effects of second-generation H1-antihistamine drugs on angiogenesis in in vivo chick chorioallantoic membrane model

3. Targeting senescence as an anticancer therapy

4. Applications of Magnetic Resonance in Model Systems: Cancer Therapeutics

5. Association of PD-1 and PDL-1 gene polymorphisms with colorectal cancer risk and prognosis

6. Effect of whey protein derivatives on cell viability, cell migration and cell cycle phases in MCF-7 cells

7. Peptide-conjugated nanoparticles for targeted photodynamic therapy

8. Does the Choice of Anaesthesia Affect Cancer? A Molecular Crosstalk between Theory and Practice

9. Metastasis-suppressor NME1 controls the invasive switch of breast cancer by regulating MT1-MMP surface clearance

10. Senescence as a therapeutically relevant response to CDK4/6 inhibitors

11. Harnessing natural killer cells for the treatment of ovarian cancer

12. Immunotherapy of Equine Sarcoids—From Early Approaches to Innovative Vaccines

13. Intraoperative cell salvage in oncological surgery: a narrative review

14. Resistance Mechanisms Influencing Oncolytic Virotherapy, a Systematic Analysis

15. Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL)

16. Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity

17. Peptide-conjugated nanoparticles for targeted photodynamic therapy

18. CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-GCB) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL

19. Gemcitabine, vinorelbine and cyclooxygenase inhibitors in the treatment of glioblastoma. Ultrastructural analyses in C6 glioma in vitro

20. MNK1/Nodal signaling promotes invasive progression of breast ductal carcinoma in situ

21. A melt-electrowritten filter for capture and culture of circulating colon cancer cells

22. A functional genetic screen defines the AKT-induced senescence signaling network

23. Advanced technological tools to study multidrug resistance in cancer

24. Harnessing natural killer cells for the treatment of ovarian cancer

25. Multivalent antibody-recruiting macromolecules : linking increased binding affinity with enhanced innate immune killing

26. Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress

27. Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly

28. Oncogenic p95HER2/611CTF primes human breast epithelial cells for metabolic stress-induced down-regulation of FLIP and activation of TRAIL-R/Caspase-8-dependent apoptosis

29. Prognostic significance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis

30. Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma

31. HAS3-induced extracellular vesicles from melanoma cells stimulate IHH mediated c-Myc upregulation via the hedgehog signaling pathway in target cells

32. Broadening the Message

33. JUNB, DUSP2, SGK1, SOCS1 and CREBBP are frequently mutated in T-cell/histiocyte-rich large B-cell lymphoma

34. A novel 3D nanofibre scaffold conserves the plasticity of glioblastoma stem cell invasion by regulating galectin-3 and integrin-β1 expression

35. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma

36. Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma

37. Working in 'NK Mode': Natural Killer Group 2 Member D and Natural Cytotoxicity Receptors in Stress-Surveillance by γδ T Cells

38. Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patients

39. A haploid genetic screen identifies the G1/S regulatory machinery as a determinant of Wee1 inhibitor sensitivity

40. Green synthesis, characterization and anticancer activity of luminescent gold nanoparticles capped with apo-α-lactalbumin

41. Selective formation of discrete versus polymeric copper organophosphates: DNA cleavage and cytotoxic activity

42. Role of Charge and Hydrophobicity in Liprotide Formation: A Molecular Dynamics Study with Experimental Constraints

43. CXCR4 Ligands

44. EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study

45. Engineering exosomes for cancer therapy

46. The Cytotoxicity of the Ajoene Analogue BisPMB in WHCO1 Oesophageal Cancer Cells Is Mediated by CHOP/GADD153

47. Combining radiotherapy with immunotherapy

48. The TAK1-NF-κB axis as therapeutic target for AML

49. Upregulation of endogenous ICAM-1 reduces ovarian cancer cell growth in the absence of immune cells

50. A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia

Catalog

Books, media, physical & digital resources